{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:20:24Z","timestamp":1791084024210,"version":"4.1.0"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0055068","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T22:02:41Z","timestamp":1360879361000},"page":"e55068","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Dopamine-Mediated Oxidation of Methionine 127 in \u03b1-Synuclein Causes Cytotoxicity and Oligomerization of \u03b1-Synuclein"],"prefix":"10.1371","volume":"8","author":[{"given":"Kazuhiro","family":"Nakaso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Teraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Mochida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Matsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"a-synuclein in filamentous inclusions of Lewy bodies from Parkinson&apos;s disease and dementia with Lewy bodies","volume":"95","author":"MG Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1098\/rstb.2008.2273","article-title":"Progress in the pathogenesis and genetics of Parkinson&apos;s disease","volume":"363","author":"Y Mizuno","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson&apos;s disease","volume":"373","author":"AJ Lees","year":"2009","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1212\/WNL.0b013e318236ef60","article-title":"Parkinson disease: the enteric nervous system spills its guts","volume":"77","author":"P Derkinderen","year":"2011","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","article-title":"Neuropathology of autonomic nervous system in Parkinson&apos;s disease","volume":"38","author":"K Wakabayashi","year":"1997","journal-title":"Eur Neurol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1007\/s100720300035","article-title":"Autonomic dysfunction in Parkinson&apos;s disease","volume":"24","author":"G Micieli","year":"2003","journal-title":"Neurol Sci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-genom-082410-101440","article-title":"Recent advances in the genetics of Parkinson&apos;s disease","volume":"12","author":"I Martin","year":"2011","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchemneu.2011.07.003","article-title":"Parkinson&apos;s disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes","volume":"42","author":"D Crosiers","year":"2011","journal-title":"J Chem Neuroanat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1136\/jnnp-2011-301205","article-title":"Molecular pathogenesis of Parkinson&apos;s disease: update","volume":"83","author":"S Saiki","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1038\/ng.485","article-title":"Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson&apos;s disease","volume":"41","author":"W Satake","year":"2009","journal-title":"Nat Genet"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"a-synuclein in Lewy bodies","volume":"388","author":"MG Spillantini","year":"1997","journal-title":"Nature"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","article-title":"Widespread alterations of alpha-synuclein in multiple system atrophy","volume":"155","author":"DW Dickson","year":"1999","journal-title":"Am J Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the a-synuclein gene identified in families with Parkinson&apos;s disease","volume":"276","author":"MH Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson&apos;s disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update","volume":"31","author":"K Nuytemans","year":"2010","journal-title":"Hum Mutat"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"a-synuclein locus triplication causes Parkinson&apos;s disease","volume":"302","author":"AB Singleton","year":"2003","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(04)17103-1","article-title":"Alpha-synuclein locus duplication as a cause of familial Parkinson&apos;s disease","volume":"364","author":"MC Chatier-Harlin","year":"2004","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0140-6736(04)17104-3","article-title":"Causal relation between alpha-synuclein gene duplication and familial Parkinson&apos;s disease","volume":"364","author":"P Ibanez","year":"2004","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cell.2005.09.028","article-title":"Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration","volume":"123","author":"S Chandra","year":"2005","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of a-synuclein: a mechanism for selective neurodegeneration in Parkinson&apos;s disease","volume":"8","author":"J Xu","year":"2002","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neures.2009.10.005","article-title":"Endogenous catecholamine enhances the dysfunction of unfolded protein response and a-synuclein oligomerization in PC12 cells overexpressing human a-synuclein","volume":"66","author":"S Ito","year":"2010","journal-title":"Neurosci Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3164\/jcbn.D-11-00030","article-title":"Cytoprotective effect of chlorogenic acid against a-synuclein-related toxicity in catecholaminergic PC12 cells","volume":"51","author":"M Teraoka","year":"2012","journal-title":"J Clin Biochem Ntur"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"K Ueda","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"10139","DOI":"10.1021\/bi00032a006","article-title":"Non-A beta component of Alzheimer&apos;s disease amyloid (NAC) is amyloidogenic","volume":"34","author":"A Iwai","year":"1995","journal-title":"Biochemistry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1523\/JNEUROSCI.08-08-02804.1988","article-title":"Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal","volume":"8","author":"L Maroteaux","year":"1988","journal-title":"J Neuosci"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"a-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"H Fujiwara","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref26","first-page":"3257","article-title":"Tyrosine and serine phosphorylation of a-synuclein have opposing effects on neurotoxicity and soluble oligomer formation","volume":"119","author":"L Chen","year":"2009","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1126\/science.290.5493.985","article-title":"Oxidative damage linked to neurodegeneration by selective a-synuclein nitration in synucleinopathy lesions","volume":"290","author":"BI Giasson","year":"2000","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.1060627","article-title":"Ubiquitination of a new form of a-Synuclein by Parkin from human brain: implication for Parkinson&apos;s disease","volume":"293","author":"H Shimura","year":"2001","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/j.freeradbiomed.2009.02.009","article-title":"Formation of dopamine-mediated a-synuclein-soluble oligomers requires methionine oxidation","volume":"46","author":"SL Leong","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"31612","DOI":"10.1074\/jbc.M704737200","article-title":"Cellular oligomerization of a-synuclein is determined by the interaction of oxidized catechols with a C-terminal sequence","volume":"282","author":"JR Mazzulli","year":"2007","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbadis.2009.12.004","article-title":"Methionine oxidation stabilizes non-toxic oligomers of alpha-synuclein through strengthening the auto-inhibitory intra-molecular long-range interactions","volume":"1802","author":"W Zhou","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1126\/science.1063522","article-title":"Kinetic stabilization of the a-synuclein protofibril by dopamine-a-synuclein adduct","volume":"294","author":"KA Conway","year":"2001","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neurobiolaging.2008.11.001","article-title":"Absence of a-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice","volume":"31","author":"A Al-Wandi","year":"2010","journal-title":"Neurobiol Aging"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.brainres.2011.01.064","article-title":"Decreased reuptake of dopamine in the dorsal striatum in the absence of alpha-synuclein","volume":"1382","author":"H Chadchankar","year":"2011","journal-title":"Brain Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/nm1314","article-title":"Dopamine covalently modifies and functionally inactivates parkin","volume":"11","author":"MJ LaVoie","year":"2005","journal-title":"Nat Med"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F","article-title":"Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase","volume":"54","author":"Y Xu","year":"1998","journal-title":"J Neurosci Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1046\/j.1471-4159.2001.00125.x","article-title":"Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter","volume":"76","author":"RE Whitehead","year":"2001","journal-title":"J Neurochem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tins.2010.09.004","article-title":"a-Synuclein and dopamine at the crossroads of Parkinson&apos;s disease","volume":"33","author":"LL Venda","year":"2010","journal-title":"Trends Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"15597","DOI":"10.1074\/jbc.M610893200","article-title":"Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with a-synuclein","volume":"282","author":"M Bisaglia","year":"2007","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.febslet.2004.12.091","article-title":"L-dopa and dopamine enhance the formation of aggregates under proteasome inhibition in PC12 cells","volume":"579","author":"Y Yoshimoto","year":"2005","journal-title":"FEBS Lett"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00401-006-0104-6","article-title":"a-synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers","volume":"112","author":"K Beyer","year":"2006","journal-title":"Acta Neuropathol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbapap.2004.10.008","article-title":"Methionine oxidation, a-synuclein and Parkinson&apos;s disease","volume":"1703","author":"CB Glaser","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0891-5849(94)00158-G","article-title":"Oxidation of methionyl residues in proteins: tools, targets, and reversal","volume":"18","author":"W Vogt","year":"1995","journal-title":"Free Radic Biol Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s12031-009-9274-8","article-title":"Clearance and phosphorylation of alpha-synuclein are inhibited in methionine sulfoxide reductase a null yeast cells","volume":"39","author":"DB Oien","year":"2009","journal-title":"J Mol Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12808","DOI":"10.1523\/JNEUROSCI.0322-07.2007","article-title":"Methionine sulphoxide reductase A and a dietary supplement S-methyl-L-cysteine prevent Parkinson&apos;s-like symptoms","volume":"27","author":"R Wassef","year":"2007","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.freeradbiomed.2008.03.022","article-title":"Methionine sulfoxide reductase A protects dopaminergic cells from Parkinson&apos;s disease-related insults","volume":"45","author":"F Liu","year":"2008","journal-title":"Free Radic Biol Med"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","article-title":"Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson\u2019s disease","volume":"5","author":"M Asanuma","year":"2003","journal-title":"Neurotox Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0055068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T19:22:01Z","timestamp":1562700121000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0055068"}},"subtitle":[],"editor":[{"given":"Wanli","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":47,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2013,2,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0055068","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}